首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1624402

全球細胞分離和分離市場：按產品類型、技術、最終用戶、應用、地區、範圍和預測

Global Cell Isolation Cell Separation Market By Cell Type, By Product, By Technique, By End User, By Application, By Geographic Scope and Forecast

出版日期: 2024年10月26日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球細胞分離市場規模及預測

2024年全球細胞分離及細胞分離市場規模為126.7億美元，預估2031年將達395.7億美元，2024年至2031年複合年增長率為16.87%。細胞分離和細胞分離是指用於從異質混合物中分離特定細胞類型以用於研究、診斷和治療目的的技術。這些方法在免疫學、癌症研究和再生醫學等領域至關重要，使科學家能夠分離和研究特定的細胞功能和行為。進展包括分離免疫細胞用於疫苗開發、純化幹細胞用於再生療法以及分離腫瘤細胞用於癌症研究。

微流體和磁活化細胞分選等技術的進步有望提高效率、精度和可擴展性，擴大在個人化醫療和細胞治療中的應用，並有望改善細胞分離和分離的未來。

全球細胞分離與細胞分離市場動態

主要市場推動因素

慢性病盛行率上升：

包括癌症和自體免疫疾病在內的慢性疾病的盛行率不斷上升，推動了對細胞分離技術的需求。據世界衛生組織 (WHO) 稱，到 2040 年，癌症患者數量預計將增加到 2950 萬人，需要先進的研究方法來進行有效的治療。

再生醫學的發展：

再生醫學領域的不斷擴大正在推動對高效細胞分離方法的需求。根據《Fortune Business Insights》的報告，到 2026 年，全球再生醫學市場預計將達到 900 億美元，這表明對分離幹細胞和祖細胞用於治療應用的需求強勁。

技術進步：

細胞分離方法的技術創新，例如微流體和自動細胞分選，正在提高細胞分離過程的效率和精確度。

加大研發投入：

生物醫學研究資金的增加正在推動細胞分離和分離技術的進步。美國國立衛生研究院 (NIH) 報告稱，2022 年生物醫學研究預算為 470 億美元，強調這項重要投資將支持開發各種應用的新型細胞分離技術。

主要課題

技術成本高：

細胞分離和分離所需的精密設備和試劑價格昂貴，限制了它們在小型實驗室和設施中的使用。

技術複雜性：

許多細胞分離技術需要專門的培訓和專業知識，這可能成為在設備簡陋的設施中廣泛使用的障礙。

樣品污染：

確保分離細胞的純度和完整性很困難，因為污染會嚴重影響研究結果和治療應用。

監管障礙：

瞭解基於細胞的產品的監管環境既複雜又耗時，並且可能會延遲新技術的市場進入。

主要趨勢

自動化集成

細胞分離和分離過程自動化程度的提高提高了效率和重現性，使研究人員更容易使用這些技術。

個性化醫療的成長

個人化醫療的趨勢正在推動對精確細胞分離技術的需求，特別是根據個別患者情況量身定制治療方法。

關注幹細胞研究

重點放在幹細胞研究及其在再生醫學中的應用，促進了針對幹細胞的細胞分離技術的進步。

合作研究和夥伴關係

學術機構、研究機構和產業利益相關者之間加強合作正在推動創新並加速新細胞分離方法的發展。

Global Cell Isolation Cell Separation Market size was valued at USD 12.67 Billion in 2024 and is projected to reach USD 39.57 Billion by 2031 , growing at a CAGR of 16.87% from 2024 to 2031. Cell isolation and cell separation refer to techniques used to separate specific cell types from a heterogeneous mixture for research, diagnostics, or therapeutic purposes. These methods are crucial in fields like immunology, cancer research, and regenerative medicine, enabling scientists to study particular cell functions and behaviors in isolation. Applications include isolating immune cells for vaccine development, purifying stem cells for regenerative therapies, and separating tumor cells for cancer research.

The future of cell isolation and separation is promising, with advancements in technologies such as microfluidics and magnetic-activated cell sorting expected to enhance efficiency, accuracy, and scalability, thus broadening their applications in personalized medicine and cellular therapies.

Global Cell Isolation Cell Separation Market Dynamics

The key market dynamics that are shaping the global cell isolation cell separation market include:

Key Market Drivers:

Rising Prevalence of Chronic Diseases:

The increasing incidence of chronic diseases, including cancer and autoimmune disorders, drives the demand for cell isolation techniques. According to the World Health Organization (WHO), cancer cases are expected to rise to 29.5 million by 2040, necessitating advanced research methods for effective treatment.

Growth in Regenerative Medicine:

The expanding field of regenerative medicine is propelling the need for efficient cell separation methods. The global regenerative medicine market is projected to reach $90 billion by 2026, as reported by Fortune Business Insights, indicating a robust demand for isolating stem and progenitor cells for therapeutic applications.

Advancements in Technology:

Technological innovations in cell separation methods, such as microfluidics and automated cell sorting, are enhancing the efficiency and accuracy of cell isolation processes.

Increasing Investment in Research and Development:

Growing funding for biomedical research is fueling advancements in cell isolation and separation technologies. The National Institutes of Health (NIH) reported a budget of $47 billion for biomedical research in 2022, highlighting a significant investment that supports the development of novel cell isolation techniques for various applications.

Key Challenges:

High Costs of Technology:

The sophisticated equipment and reagents required for cell isolation and separation can be expensive, limiting access for smaller laboratories and institutions.

Technical Complexity:

Many cell separation techniques require specialized training and expertise, which can pose a barrier to widespread adoption in less equipped facilities.

Sample Contamination:

Ensuring the purity and integrity of isolated cells is challenging, as contamination can significantly affect research outcomes and therapeutic applications.

Regulatory Hurdles:

Navigating the regulatory landscape for cell-based products can be complex and time-consuming, potentially delaying market entry for new technologies.

Key Trends:

Integration of Automation

: Increasing automation in cell isolation and separation processes is enhancing efficiency and reproducibility, making these techniques more accessible to researchers.

Personalized Medicine Growth

: The trend towards personalized medicine is driving demand for precise cell isolation techniques, particularly for tailoring therapies based on individual patient profiles.

Focus on Stem Cell Research

: There is a growing emphasis on stem cell research and applications in regenerative medicine, prompting advancements in cell isolation technologies tailored for stem cells.

Collaboration and Partnerships

: Increased collaboration between academic institutions, research organizations, and industry players is fostering innovation and accelerating the development of novel cell separation methods.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Cell Isolation Cell Separation Market Regional Analysis

Here is a more detailed regional analysis of the global cell isolation cell separation market:

North America:

North America is the dominant region in the cell isolation and cell separation market, primarily due to its advanced healthcare infrastructure and substantial investment in biomedical research. The presence of leading pharmaceutical companies and research institutions drives demand for innovative cell isolation technologies. According to the National Institutes of Health (NIH), the U.S. alone allocated approximately $47 billion for biomedical research in 2022, significantly contributing to the development and application of cell separation techniques across various medical fields.

Moreover, the region's focus on personalized medicine and regenerative therapies has spurred the adoption of cell isolation methods. The increasing prevalence of chronic diseases, such as cancer and diabetes, necessitates precise cell-based treatments, further driving market growth. Reports indicate that the North American market for cell isolation technologies is expected to account for over 40% of the global market share by 2025, underscoring its leading position in this sector.

Asia Pacific:

The Asia Pacific region is emerging as the fastest growing market for cell isolation and cell separation technologies, driven by rapid advancements in healthcare and biotechnology. Countries like China and India are investing heavily in their biomedical research capabilities, aiming to enhance their global competitiveness. The Asian Development Bank reported that health expenditures in Asia are expected to reach $1 trillion by 2025, propelling demand for effective cell isolation methods in both research and clinical settings.

Additionally, the growing focus on stem cell research and regenerative medicine in Asia Pacific is a significant growth driver. The region's commitment to addressing chronic diseases and age-related health issues is fostering an environment conducive to innovation in cell separation technologies. As a result, the Asia Pacific market is projected to grow at a compound annual growth rate (CAGR) of over 10% from 2024 to 2030, highlighting its potential to surpass other regions in the coming years.

Global Cell Isolation Cell Separation Market: Segmentation Analysis

The Global Cell Isolation Cell Separation Market is segmented on the basis of By Cell Type, By Product, By Technique, By End User, By Application, and By Geography.

Global Cell Isolation Cell Separation Market, By Cell Type

Human Cells
Animal Cells

Based on Cell Type, the Global Cell Isolation Cell Separation Market is segmented into Human Cells, Animal Cells. The Animal Cells segment is dominant due to its extensive use in animal feed applications, where calcium formate enhances nutrition and health. However, the Human Cells segment is the fastest growing, driven by increasing research in regenerative medicine and cell therapies, which necessitate high-quality additives like calcium formate for cell culture and preservation.

Global Cell Isolation Cell Separation Market, By Product

Consumables
Instruments

Based on Product, the Global Cell Isolation Cell Separation Market is segmented into Consumables, Instruments. The Consumables segment is dominant, primarily due to the widespread use of calcium formate in various applications such as animal feed and concrete additives. Conversely, the Instruments segment is the fastest growing, driven by advancements in technology and increased demand for sophisticated equipment that improves the efficiency of calcium formate application processes.

Global Cell Isolation Cell Separation Market, By Technique

Centrifugation-Based Cell Isolation
Surface Marker-Based Cell Isolation
Filtration-Based Cell Isolation

Based on Technique, the Global Cell Isolation Cell Separation Market is segmented into Centrifugation-Based Cell Isolation, Surface Marker-Based Cell Isolation, Filtration-Based Cell Isolation. Surface Marker-Based Cell Isolation is the dominant segment, widely utilized for its specificity and efficiency in isolating particular cell types, particularly in research and clinical applications. Meanwhile, Centrifugation-Based Cell Isolation is the fastest growing segment, driven by advancements in centrifugation technologies that enhance separation processes and reduce processing time, making it increasingly popular in various biomedical fields.

Global Cell Isolation Cell Separation Market, By End User

Research Laboratories & Institutes
Hospitals & Diagnostic Laboratories
Cell Banks
Biotechnology & Biopharmaceutical Companies

Based on Product, the Global Cell Isolation Cell Separation Market is segmented into Research Laboratories & Institutes, Hospitals & Diagnostic Laboratories, Cell Banks, Biotechnology & Biopharmaceutical Companies. Research Laboratories & Institutes is the dominant segment, primarily due to the extensive use of calcium formate in various research applications, including cell culture and experimental procedures. However, the Biotechnology & Biopharmaceutical Companies segment is the fastest growing, driven by the increasing focus on developing innovative therapies and the rising demand for cell-based products, which necessitate advanced cell isolation techniques.

Global Cell Isolation Cell Separation Market, By Product

Biomolecule Isolation
Cancer Research
Stem Cell Research
Tissue Regeneration
In Vitro Diagnostics
Therapeutics

Based on Application, the Global Cell Isolation Cell Separation Market is segmented into Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue Regeneration, In Vitro Diagnostics, Therapeutics. Cancer Research is the dominant segment due to the high demand for effective cell isolation techniques, which are critical for developing targeted cancer therapies. On the other hand, Stem Cell Research is the fastest growing segment, driven by the increasing focus on regenerative medicine and therapeutic advancements that require precise cell isolation and preservation methods.

Global Cell Isolation Cell Separation Market, By Geography

North America
Europe
Asia Pacific
Rest of the World

Based on the Geography, the Global Cell Isolation Cell Separation Market are classified into North America, Europe, Asia Pacific, and Rest of World. North America is the dominant region in the cell isolation and cell separation market, primarily due to its advanced healthcare infrastructure and substantial investment in biomedical research. The Asia Pacific region is emerging as the fastest growing market for cell isolation and cell separation technologies, driven by rapid advancements in healthcare and biotechnology.

Key Players

The "Global Cell Isolation Cell Separation Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market
Beckman Coulter (Subsidiary of Danaher Corporation), Becton, Dickinson and Company, GE Healthcare (A Fully Owned Subsidiary of General Electric Company), Merck KGaA, Thermo Fisher Scientific Inc., Miltenyi Biotec.
Our
market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Global Cell Isolation Cell Separation Market: Recent Developments
In August 2024 Becton, Dickinson and Company announced the launch of a new line of advanced cell separation kits that utilize innovative microfluidics technology. These kits are designed to enhance the efficiency and accuracy of isolating specific cell types for research and clinical applications, significantly improving throughput and reducing processing times for laboratories.
In July 2024 Miltenyi Biotec unveiled a state-of-the-art cell sorting system that integrates artificial intelligence for optimized sorting protocols. This system allows researchers to achieve higher purity levels in isolated cell populations while reducing user intervention, making it easier for laboratories to handle complex cell separation tasks.

1 INTRODUCTION OF GLOBAL CELL ISOLATION/CELL SEPARATION MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL CELL ISOLATION/CELL SEPARATION MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL CELL ISOLATION/CELL SEPARATION MARKET, BY CELL TYPE

5.1 Overview
5.2 Human Cells
5.3 Animal Cells

6 GLOBAL CELL ISOLATION/CELL SEPARATION MARKET, BY PRODUCT

6.1 Overview
6.2 Consumables
6.3 Instruments

7 GLOBAL CELL ISOLATION/CELL SEPARATION MARKET, BY TECHNIQUE

7.1 Overview
7.2 Centrifugation-Based Cell Isolation
7.3 Surface Marker-Based Cell Isolation
7.4 Filtration-Based Cell Isolation

8 GLOBAL CELL ISOLATION/CELL SEPARATION MARKET, BY END USER

8.1 Overview
8.2 Research Laboratories & Institutes
8.3 Hospitals & Diagnostic Laboratories
8.4 Cell Banks
8.5 Biotechnology & Biopharmaceutical Companies

9 GLOBAL CELL ISOLATION/CELL SEPARATION MARKET, BY APPLICATION

9.1 Overview
9.2 Biomolecule Isolation
9.3 Cancer Research
9.4 Stem Cell Research
9.5 Tissue Regeneration
9.6 In Vitro Diagnostics
9.7 Therapeutics

10 GLOBAL CELL ISOLATION/CELL SEPARATION MARKET, BY GEOGRAPHY

10.1 Overview
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
- 10.2.3 Mexico
10.3 Europe
- 10.3.1 Germany
- 10.3.2 U.K.
- 10.3.3 France
- 10.3.4 Rest of Europe
10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 Rest of Asia Pacific
10.5 Rest of the World
- 10.5.1 Latin America
- 10.5.2 Middle East and Africa

11 GLOBAL CELL ISOLATION/CELL SEPARATION MARKET COMPETITIVE LANDSCAPE

11.1 Overview
11.2 Company Market Ranking
11.3 Key Development Strategies

12 COMPANY PROFILES

12.1 Beckman Coulter (Subsidiary of Danaher Corporation)
- 12.1.1 Overview
- 12.1.2 Financial Performance
- 12.1.3 Product Outlook
- 12.1.4 Key Developments
12.2 Becton, Dickinson and Company
- 12.2.1 Overview
- 12.2.2 Financial Performance
- 12.2.3 Product Outlook
- 12.2.4 Key Developments
12.3 GE Healthcare (A Fully Owned Subsidiary of General Electric Company)
- 12.3.1 Overview
- 12.3.2 Financial Performance
- 12.3.3 Product Outlook
- 12.3.4 Key Developments
12.4 Merck KGaA
- 12.4.1 Overview
- 12.4.2 Financial Performance
- 12.4.3 Product Outlook
- 12.4.4 Key Developments
12.5 Thermo Fisher Scientific Inc.
- 12.5.1 Overview
- 12.5.2 Financial Performance
- 12.5.3 Product Outlook
- 12.5.4 Key Developments
12.6 Miltenyi Biotec
- 12.6.1 Overview
- 12.6.2 Financial Performance
- 12.6.3 Product Outlook
- 12.6.4 Key Developments